** Berenberg ups Belgian chipmaker Melexis MLXS.BR to
"buy" from "hold", seeing an attractive entry point into
company's long-term growth story
** It estimates the company will have managed to grow its
revenue at an 11% CAGR over the seven years to FY 2023, without
making any acquisitions
** "The guidance revealed at its recent capital markets day
envisages a double-digit CAGR for the next seven too," adds the
brokerage in a note
** Berenberg outpoints market's short-term concerns about
automotive demand and potential upcoming inventory corrections,
but believes Melexis' valuation multiples offer an attractive
long-term opportunity to own
** While it thinks that peer X-FAB XFAB.PA is a better
short-term play given the cheaper valuation and greater
operating leverage, Berenberg considers Melexis to be the
better-quality sibling
** Out of 12 analysts that cover Melexis, five rate the
stock "strong buy" or "buy," six rate "hold" and one rates the
stock "sell"
(Reporting by Clement Martinot)
((Clement.martinot@tr.com))